Results 11 to 20 of about 12,289 (268)

A Rare Case of Uterine Rupture in the First Trimester of Pregnancy Secondary to Placenta Accreta Spectrum. [PDF]

open access: yesClin Case Rep
ABSTRACT Uterine rupture in the first trimester is a rare but life‐threatening condition that must be ruled out in an otherwise hemodynamically stable patient with complex free fluid in the abdomen. Early identification of placenta accreta spectrum is key to provide adequate treatment and minimize mortality.
Huertas Ayala C   +3 more
europepmc   +2 more sources

Placenta Accreta spectrum

open access: yesObstetrics and Gynecology Clinics of North America, 2022
Histopathological examination of products of conception from miscarriages is part of routine clinical practice. The extent of additional clinically relevant information provided by this investigation in the setting of recurrent spontaneous abortion remains uncertain.
KARAMAN, ERBİL   +2 more
  +7 more sources

Placenta accreta spectrum: treatment consensus in a resource-limited settingAJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2023
BACKGROUND: Management options for placenta accreta spectrum disorder are multiple, without a clear picture of which one is superior. Management guidelines describe the use of a wide range of human and technological resources that are not always ...
Albaro José Nieto-Calvache, MD   +4 more
doaj   +1 more source

Placenta Accreta Overlying a Caesarean Section Scar: A 10-Year Experience in a Tertiary-Care Centre in Portugal

open access: yesActa Médica Portuguesa, 2021
Introduction: Placenta accreta spectrum disorders are among the leading causes of maternal morbidity and mortality and their prevalence is likely to increase in the future.
Margarida Cal   +3 more
doaj   +1 more source

Placenta accreta spectrum-a catastrophic situation in obstetrics [PDF]

open access: yesObstetrics & Gynecology Science, 2021
Placenta accreta is a significant obstetric complication in which the placenta is completely or focally adherent to the myometrium. The worldwide incidence of placenta accreta spectrum (PAS) is increasing day by day, mostly due to the increasing trends ...
Bhabani Pegu   +3 more
doaj   +1 more source

miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions

open access: yesFrontiers in Molecular Biosciences, 2021
Objective: To clarify the role of microRNA-193a-3p (miR-193a-3p) in the pathogenesis of placenta accreta spectrum.Methods: The placental tissue expression levels of miR-193a-3p and Ephrin-B2 (EFNB2) were compared between a placenta accreta spectrum group
Na Li   +9 more
doaj   +1 more source

Impact of IVF/ICSI on grades of placenta accreta spectrum disorders and pregnancy outcomes. [PDF]

open access: goldReprod Health
Hu M   +15 more
europepmc   +3 more sources

Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder [version 4; peer review: 2 approved]

open access: yesF1000Research, 2022
Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta  is increasingly seen today as the rate of cesarean section increases, however, the exact ...
Bancin Berry Eka Parda   +3 more
doaj   +1 more source

Emergency cesarean hysterectomy for placenta accreta spectrum: Estimation of maternal morbidity and mortality. [PDF]

open access: yesInt J Gynaecol Obstet
International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1414-1417, December 2025.
Matsuo K   +6 more
europepmc   +2 more sources

Placenta Accreta Spectrum Outcomes Using Tourniquet and Forceps for Vascular Control

open access: yesFrontiers in Medicine, 2021
Objective: To evaluate the use of tourniquet and forceps to reduce bleeding during surgical treatment of severe placenta accreta spectrum (placenta increta and placenta percreta).Methods: A tourniquet was used in the lower part of the uterus during ...
Jingrui Huang   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy